Contributors |
|
ix | |
Preface |
|
xv | |
Acknowledgements |
|
xvii | |
Foreword |
|
xix | |
SECTION 1 Antioxidants and Their Mechanisms of Action |
|
|
Nutritional Antioxidants and Disease Prevention: Mechanisms of Action |
|
|
1 | (14) |
|
|
Potential Role of Antioxidant Vitamins |
|
|
15 | (12) |
|
|
Immunological Role of Antioxidant Vitamins |
|
|
27 | (16) |
|
|
The Effect of Antioxidants on the Production of Lipid Oxidation Products and Transfer of Free Radicals in Oxidized Lipidarotein Systems |
|
|
43 | (12) |
|
|
|
Regulation of the Low-density Lipoprotein Receptor by Antioxidants |
|
|
55 | (16) |
|
|
|
|
|
Carotenoid and Lipid/Lipoprotein Correlates of the Susceptibility of Low-density Lipoprotein to Oxidation in Humans |
|
|
71 | (12) |
|
|
|
|
|
Antioxidation and Evolution: Dietary Restriction; and Alterations in Molecular Processes |
|
|
83 | (12) |
|
|
|
SECTION 2 Food Factors as Antioxidants |
|
|
Evaluation of the Contribution of Flavanols and Caffeine to the Anticarcinogenic Potential of Tea |
|
|
95 | (14) |
|
|
Antioxidant Effects of Plant Phenolic Compounds |
|
|
109 | (14) |
|
|
Antioxidant Effects of Soybean Isoflavones |
|
|
123 | (8) |
|
|
|
Action of Ginkgo biloba as an Antioxidant |
|
|
131 | (10) |
|
|
|
|
|
|
Whole Foods, Antioxidants and Health |
|
|
141 | (10) |
|
SECTION 3 Coronary Heart Disease |
|
|
Antioxidants and Their Role in Coronary Heart Disease Prevention |
|
|
151 | (14) |
|
|
|
Effect of Antioxidants on Atherogenesis |
|
|
165 | (10) |
|
|
|
|
Flavonoids and Other Phytochemicals in Relation to Coronary Heart Disease |
|
|
175 | (14) |
|
|
|
|
Antioxidant Vitamins and Coenzyme Q10 in the Prevention and Treatment of Coronary Artery Disease and Diabetes |
|
|
189 | (16) |
|
|
|
|
|
Fruit, Vegetables and Antioxidants: Their Role in the Prevention of Cardiovascular and Other Diseases |
|
|
205 | (12) |
|
|
|
SECTION 4 Malignant Disease |
|
|
Antioxidants and the Prevention of Cancer |
|
|
217 | (18) |
|
|
|
The Role of β-Carotene and Vitamin E in the Treatment of early Gastric Premalignant Lesions: Biochemical and Clinical Aspects |
|
|
235 | (14) |
|
|
Vladimir A. Draudin-Krylenko |
|
SECTION 5 Other Diseases |
|
|
Oxidative Stress, Vitamin E and Diabetes |
|
|
249 | (10) |
|
|
An Investigation of in Vivo Antioxidant Status and v DNA Damage in Patients with IDDM |
|
|
259 | (12) |
|
|
|
|
|
|
|
Nutrition and the Risk for Cataract |
|
|
271 | (14) |
|
|
|
|
Reactive Oxygen Species and Age-related Macular Degeneration |
|
|
285 | (8) |
|
|
|
|
|
|
Antioxidants and Respiratory Disease |
|
|
293 | (20) |
|
|
|
|
Oxidative Stress and Antioxidants in Cystic Fibrosis |
|
|
313 | (22) |
|
|
|
|
The Influence of Antioxidants on Cognitive Decline in the Elderly |
|
|
335 | (16) |
|
|
|
|
Schizophrenia: Role of Oxidative Stress and Essential Fatty Acids |
|
|
351 | (16) |
|
|
|
β-Amyloid and Oxidative Stress in the Pathogenesis of Alzheimer's Disease |
|
|
367 | (26) |
|
|
|
|
|
|
|
SECTION 6 Indicators of Oxidative Stress |
|
|
Isoprostanes: Indicators of Oxidative Stress tn Vivo and Their Biological Activity |
|
|
393 | (18) |
|
|
|
Indicators of Oxidative Stress, Antioxidants and Human Health |
|
|
411 | (12) |
|
|
|
|
|
|
SECTION 7 Consumer Issues |
|
|
Consumer Issues in Relation to Antioxidants |
|
|
423 | (14) |
|
Index |
|
437 | |